Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Science Peptide Biological Technology is a professional peptide manufacturer and service provider headquartered in Shanghai, China. The company specializes in custom peptide synthesis, offering a diverse portfolio that includes catalog peptides, pharmaceutical-grade peptides, and cosmetic peptides. They provide comprehensive services ranging from small-scale research samples to large-scale commercial production, utilizing both solid-phase and liquid-phase synthesis technologies. Their technical capabilities encompass various modifications such as phosphorylation, biotinylation, and isotope labeling to meet specific client requirements. Science Peptide serves a global clientele across the pharmaceutical, biotechnology, and academic sectors, supporting drug discovery and development efforts. The company maintains rigorous quality control standards, ensuring high purity and accuracy through advanced analytical techniques like HPLC and mass spectrometry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Science Peptide Biological Technology.